January 20, 2025 - 18:51

In the 2024 financial advisory rankings for mergers and acquisitions (M&A) in South America, Goldman Sachs has emerged as the leader by deal value, facilitating transactions worth an impressive $12.7 billion. This achievement highlights the firm's strong presence and expertise in the region's financial markets, showcasing its ability to navigate complex deals and provide strategic guidance to clients.
On the other hand, UBS has distinguished itself by leading in deal volume, successfully advising on 12 transactions throughout the year. This accomplishment reflects UBS's robust operational capabilities and its commitment to serving a diverse range of clients, from large corporations to emerging businesses seeking growth opportunities.
The competitive landscape of M&A advisory in South America continues to evolve, with both firms demonstrating their strengths in different facets of the market. As the region experiences ongoing economic changes, the demand for expert financial advisory services is expected to remain high, positioning both Goldman Sachs and UBS for continued success in the future.
March 17, 2026 - 05:46
Virginia joins multi-state lawsuit against OneMain FinancialVirginia has officially joined a coalition of a dozen states in filing a lawsuit against OneMain Financial, a major consumer loan company. The legal action, announced by Attorney General Jay Jones,...
March 16, 2026 - 02:28
Barclays Lifts PT on EOG Resources (EOG) to $140 From $133In a recent move underscoring confidence in the energy sector, investment bank Barclays has increased its price target for EOG Resources, Inc. The firm lifted its target to $140 per share, up from...
March 15, 2026 - 05:53
Peak War Panic Predicted to Grip Markets Within WeeksA leading market strategist warns that global financial markets are likely to experience a peak period of war-induced panic within the next one to three weeks. This forecast comes as both the...
March 14, 2026 - 22:13
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price PerformanceThe valuation of Brazilian medical education leader Afya is under scrutiny following a period of mixed performance for its shares. While the stock experienced a modest single-day gain of...